Examkin

Question

Difficulty: MediumMonitoring and Treatment Evaluation

A 6262-year-old man with a history of alcohol-associated cirrhosis is evaluated in the hospital on day 33 of admission. He was initially brought to the emergency department by his wife due to increasing lethargy, confusion, and an altered sleep-wake cycle over the preceding 4848 hours. On admission, he had not had a bowel movement for four days. Initial examination revealed marked disorientation to time and place, and pronounced asterixis. Laboratory studies on admission showed a serum ammonia level of 135μmol/L135 \mu mol/L (normal: 15−45μmol/L15-45 \mu mol/L) and an International Normalized Ratio (INR) of 1.71.7. He was admitted and promptly started on oral lactulose.

Today, the patient is awake, alert, and fully oriented. He is interacting appropriately with the medical staff. He no longer exhibits asterixis. He reports having three soft bowel movements over the past 2424 hours. Vital signs are within normal limits. A repeat basic metabolic panel is unremarkable, his INR is 1.61.6, and his serum ammonia level is 118μmol/L118 \mu mol/L.

Which of the following is the most appropriate next step in the management of this patient?

  1. Maintain the current lactulose regimen without dosage modification.Answer
  2. B
    Increase the lactulose dosage to achieve a normal serum ammonia level.
  3. C
    Administer fresh frozen plasma to correct the prolonged coagulation time.
  4. D
    Obtain a non-contrast computed tomography scan of the head.
  5. E
    Prescribe oral lorazepam at bedtime to regulate the patient's sleep-wake cycle.

Answer

Maintain the current lactulose regimen without dosage modification.
The correct action is to maintain the current lactulose regimen without modification. The monitoring and treatment evaluation of hepatic encephalopathy relies primarily on clinical assessment rather than laboratory values. The therapeutic goal of lactulose is two-fold: achieving clinical resolution of altered mental status (and associated signs like asterixis) and producing 22 to 33 soft bowel movements daily to facilitate the excretion of nitrogenous waste. This patient is fully oriented and is experiencing the target number of bowel movements. Although his serum ammonia level remains elevated, ammonia levels correlate poorly with the degree of encephalopathy in chronic liver disease and should not be used as a target for therapy titration. Therefore, the current regimen is optimal and should be continued as maintenance therapy.

Step-by-Step Solution

1
Evaluate the patient's clinical response to the current therapy.
The patient's mental status has normalized, and asterixis has completely resolved.
Clinical presentation (mental status and physical exam findings) is the primary indicator of hepatic encephalopathy resolution.
2
Evaluate the patient's physiological response to the medication dosing.
The patient is having three soft bowel movements daily.
The therapeutic goal of lactulose is to produce 2 to 3 soft bowel movements per day to ensure adequate gut ammonia excretion without causing profound volume depletion.
3
Determine the necessary intervention based on the clinical evaluation.
Maintain the current therapeutic regimen.
The patient has achieved optimal clinical and physiological therapeutic responses, rendering dosage changes or further diagnostic workup unnecessary despite the persistent elevation in serum ammonia.

Key Concept

The management of hepatic encephalopathy is guided by the patient's clinical status and bowel movement frequency (target of 2-3 daily), not by serum ammonia levels.
Estimated Time:1m 30s
Rate this question

Topics

Monitoring and Treatment Evaluation

More questions from this topic